Top 50 Medical Startup Investors in Israel (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
OurCrowd
VC Fund
|
19 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $593k–$62M |
|
Pontifax
VC Fund
|
11 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$130M |
|
Israel Innovation Authority
VC Fund
|
10 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $100k–$6M |
|
Trendlines Group
VC Fund
|
9 | Israel, Singapore, United Kingdom | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $650k–$62M |
|
Triventures
VC Fund
|
6 | United States, Israel, Ireland | Series A, Series B, Venture - Series Unknown | Health Care, Medical Device, Medical | $1.5M–$28M |
|
Cybele Holdings
VC Fund
|
6 | Israel, United States, Cyprus | Post-IPO Equity, Venture - Series Unknown, Series D | Health Care, Real Estate, Biotechnology | $524k–$98M |
|
HBL Hadasit Bio Holdings
VC Fund
|
6 | Israel | Venture - Series Unknown, Seed, Series A | Biotechnology, Medical, Health Care | $10M–$47M |
|
aMoon Fund
VC Fund
|
4 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Vertex Ventures Israel
VC Fund
|
4 | Israel, United States, Canada | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $3.5M–$100M |
|
Docor International Management
VC Fund
|
4 | Israel, United States | Series C, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $8M–$22M |
|
S2G Investments
VC Fund
|
4 | United States, Canada, Israel | Series A, Series B, Venture - Series Unknown | Food and Beverage, Agriculture, Biotechnology | $3.9M–$100M |
|
Agriline
VC Fund
|
4 | Israel | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Biotechnology | $1.3M–$17M |
|
Elron Ventures
VC Fund
|
4 | Israel, United States, China | Series A, Seed | Information Technology, Software, Cyber Security | $1M–$17M |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
Terra Venture Partners
VC Fund
|
3 | Israel, United States | Seed, Series A, Series B | Software, Health Care, Machine Learning | $1M–$30M |
|
TechWald Holding S.p.A.
VC Fund
|
3 | Israel, United States, Switzerland | Series A, Series B, Series C | Health Care, Medical Device, Medical | $3.6M–$60M |
|
Insight Partners
VC Fund
|
3 | United States, Israel, Germany | Series B, Series A, Series C | Software, Artificial Intelligence, SaaS | $12M–$150M |
|
Robin Hood Ventures
VC Fund
|
3 | United States, Canada, Israel | Seed, Series A, Convertible Note | Software, Health Care, Biotechnology | $26k–$11M |
|
Tal Ventures
VC Fund
|
3 | Israel, United States, Cyprus | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $2.1M–$25M |
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
|
Mindset Ventures
VC Fund
|
3 | United States, Israel, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Machine Learning | $1.9M–$35M |
|
Qure Ventures
VC Fund
|
3 | United States, Israel | Series A, Series B, Series C | Health Care, Medical Device, Medical | $8.8M–$20M |
|
Neo Ventures
VC Fund
|
3 | United States, United Kingdom, Israel | Seed, Series A | Software, Artificial Intelligence, SaaS | $500k–$24M |
|
GE Ventures
VC Fund
|
3 | United States, Israel, Canada | Series B, Series A, Series C | Health Care, Software, Enterprise Software | $6M–$70M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $9.8M–$160M |
|
Alon Medtech Ventures
VC Fund
|
3 | Israel, United States | Seed, Venture - Series Unknown, Series B | Health Care, Medical, Medical Device | $900k–$2.2M |
|
Shimon Eckhouse
Angel
|
3 | Israel | Seed, Series A | Medical, Biotechnology, Fitness | |
|
EISMEA
VC Fund
|
3 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Software, Biotechnology | $53k–$2.6M |
|
MTIP AG
VC Fund
|
3 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Medical, Artificial Intelligence | $1.5M–$80M |
|
CE Ventures (CEIIF)
VC Fund
|
3 | Israel, United States, India | Series B, Series A, Series C | Software, Analytics, Big Data | $3.5M–$40M |
|
Technion - Israel Institute of Technology
VC Fund
|
3 | Israel, United States | Seed, Grant, Series A | Medical, Health Care, Therapeutics | $1.2M–$20M |
|
XTX Ventures
VC Fund
|
3 | United Kingdom, United States, Israel | Series A, Seed, Series B | Artificial Intelligence, Software, Machine Learning | $2M–$200M |
|
Connecticut Innovations
VC Fund
|
3 | United States, Israel, Canada | Seed, Series A, Series B | Health Care, Biotechnology, Software | $150k–$75M |
|
Good Company
VC Fund
|
3 | Israel, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Recruiting | $400k–$22M |
|
Alumni Ventures
VC Fund
|
3 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $850k–$75M |
|
Entrée Capital
VC Fund
|
3 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, FinTech, Financial Services | $1.5M–$54M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
3 | Israel, United States | Series A, Series B, Series C | Health Care, Biotechnology, Medical Device | $4.4M–$55M |
|
Clal Biotechnology Industries
VC Fund
|
3 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical Device | $4M–$55M |
|
ShengJing360
VC Fund
|
3 | China, Israel, Malaysia | Series A, Series B, Seed | Artificial Intelligence, Manufacturing, Biotechnology | $2M–$120M |
|
Accelmed
VC Fund
|
3 | United States, Israel | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
Firstime Venture Capital
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, Machine Learning | $600k–$42M |
|
Arc Impact
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Pre-Seed | Health Care, Food and Beverage, Artificial Intelligence | $2M–$20M |
|
fresh.fund
VC Fund
|
2 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $300k–$21M |
|
GlenRock Israel
VC Fund
|
2 | Israel, United States | Seed, Series A, Series B | Software, Health Care, Cyber Security | $100k–$30M |
|
Israel Healthcare Ventures
VC Fund
|
2 | Israel, United States | Series D, Series F | Health Care, Medical Device, Medical | $1.2M–$40M |
|
Grove Ventures
VC Fund
|
2 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.5M–$74M |
|
Hanaco Venture Capital
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Seed, Series B | Software, FinTech, Financial Services | $2.5M–$56M |
|
Eclipse
VC Fund
|
2 | United States, Canada, Israel | Series A, Series B, Seed | Software, Artificial Intelligence, Robotics | $2M–$100M |
|
Lightspeed Venture Partners
VC Fund
|
2 | United States, India, Israel | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $2M–$125M |
|
Group 11
VC Fund
|
2 | United States, Israel | Series A, Series B, Seed | FinTech, Software, Financial Services | $1.5M–$100M |
| Access all 667 investors in Israel Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 387
- Round size: Seed $593k–$8M; Series A $3M–$22M; Series B $6.3M–$62M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely actively investing — fresh fund, raised $230k in 2026
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
- MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 122
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Crystalys Therapeutics — Transforming care for people living with gout.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 217
- Round size: Seed $400k–$6M; Grant $130k–$3.5M; Pre-Seed $100k–$2.1M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $10M in 2023
Portfolio highlights
- Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
- PulseNmore — Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
- GeoRank Studio — GeoRank Studio is a specialist SEO, Generative Engine Optimisation (GEO), and Reputation Management agency helping businesses across the UK, EU, and US gain visibility in both traditional and AI-powered search.As AI search engines including ChatGPT, Perplexity, and Google AI Overviews now answer a growing share of commercial queries without aclick, GeoRank Studio helps businesses adapt. We implement the technical and content changes needed to get brands cited in AI-generated answers — a discipline known as Generative Engine Optimisation or GEO.Our core services include technical SEO audits and full implementation, GEO optimisation including FAQPage schema markup, entity optimisation, and AI crawler configuration, reputation management including review removal from Google and Trustpilot, negative SERP suppression, and monthly AI citation tracking reports.GeoRank Studio was founded in 2022 and operates fully remotely, serving clients in professional services, SaaS, hospitality, luxury retail, and e-commerce. All packages include a 14-day money-back guarantee.Official Website: georankstudio.com
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $650k–$4.1M; Venture - Series Unknown $1M–$62M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Series A $6M–$24M; Series B $6M–$28M; Venture - Series Unknown $1.5M–$20M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $100M in 2015
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
Cybele Group is a full service consulting and financial services firm, which provides investment banking, brokerage and asset management services to both corporations and a wide array of clients, ranging from individuals and small businesses to the world's largest corporations and governments.
Show more...Investment focus
- Industry: Health Care, Real Estate, Biotechnology
- Stage:Post-IPO Equity, Venture - Series Unknown, Series D
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 73
- Round size: Post-IPO Equity $787k–$77M; Venture - Series Unknown $524k–$98M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Silverbyte — Optima is an international, top notch Hotel Management Software solution for medium to high end hotels and groups with over 1000 installations in 34 countries.
- Cannabotech — Cannabotech develop, and assimilate the medicinal properties of Cannabinoids & Mushrooms, integrated with cutting-edge technologies at world-class standards.
- Smart Agro — Smart Agro specializes in investing and improving companies in the agro-tech fields.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 11
- Round size: Venture - Series Unknown $10M–$47M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 80
- Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $340M in 2022
Portfolio highlights
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Hopscotch Primary Care — We provide primary care services to seniors on Medicare, offering more time with your doctor, and a full care team to support all of your healthcare needs.
We partner early with global-minded entrepreneurs seeking to disrupt large markets
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 189
- Round size: Series A $3.5M–$28M; Series B $5M–$35M; Series C $5.6M–$100M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $170M in 2022
Portfolio highlights
- Rylo — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
- Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
- Adaptive6 — Cloud Cost Governance: Govern Cost Across Your Cloud and Code. Prevent and Remediate Waste. At Scale.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series C, Venture - Series Unknown
- Geography: Israel, United States
Investor stats
- Total investments: 18
- Round size: Series C $13M–$22M; Venture - Series Unknown $8M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
- SP Nano — SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin.
- Raziel Therapeutics — Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Food and Beverage, Agriculture, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 229
- Round size: Series A $4M–$55M; Series B $3.9M–$100M; Venture - Series Unknown $4.3M–$100M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $1B in 2026
Portfolio highlights
- Kanin Energy — Our solution transforms industrial waste heat into clean baseload electricity, boosting energy efficiency, cutting costs, improving reliability, and lowering
- Corvus Robotics — Autonomous inventory intelligence for the physical economy. Corvus Robotics drones and AI forklift sensors count inventory in Fortune 500 warehouses.
- Energy Vault — Energy Vault creates gravity and kinetic energy-based, long-duration energy storage solutions that are transforming the world's approach to energy storage.
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Cyber Security
- Stage:Series A, Seed
- Geography: Israel, United States, China
Investor stats
- Total investments: 66
- Round size: Seed $1.5M–$15M; Series A $1M–$17M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Brainsgate — BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developedthe ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to dental treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.
- Raven.io — Secure apps with our Runtime Protection Platform. De-prioritize 99% of vulnerabilities with runtime reachability and prevent exploits, zero-days and supply chain attacks with intelligent, library-level policies.
- CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $9.6M in 2021
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 10
- Round size: Series A $3.6M–$7.1M; Series B $8.5M–$48M; Series C $9.3M–$60M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, Germany
Investor stats
- Total investments: 1445
- Round size: Series A $12M–$70M; Series B $17M–$110M; Series C $25M–$150M
- Lead/follow: 68% lead, 32% follow
- Last fund: Likely actively investing — fresh fund, raised $13B in 2025
Portfolio highlights
- Vela — Vela is a leading independent provider of data and execution technology for global multi-asset electronic trading. Our software enables clients to rapidly access global liquidity, markets, and data sources for superior execution. We help firms successfully differentiate and innovate in an ever-changing, increasingly regulated, and fiercelycompetitive landscape, while also reducing total cost of ownership. Vela’s market data, execution and automated trading software deliver a unique, ultra-low latency technology stack to simplify and streamline electronic trading. We leverage the latest innovations in technology to deliver cutting-edge performance, features and reliability. Our modular stack provides access to a comprehensive set of trading data and risk APIs and can be delivered “as-a-Service” from multiple co-location data centers globally. With access to more than 250 venues, Vela provides global coverage across all major asset classes. Clients are supported by an award-winning team of technical and business experts available 24x7 from our multiple offices in the U.S., Europe, and Asia. Vela’s clients include traders, market makers, brokers, banks, investment firms, exchanges, and other market participants.
- Pluralsight — Pluralsight is the technology workforce development company that helps teams know more and work better together with stronger skills, improved processes and informed leaders.
- Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 165
- Round size: Seed $210k–$4.3M; Series A $180k–$11M; Convertible Note $26k–$560k
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Aseon Labs — Robotic pitstops for self driving cars. A depot in a box for charging, cleaning & inspecting AVs directly in operating zones. Backed by @ycombinator
- Cooler Heads — Cooler Heads develops cold caps designed for chemotherapy patients.
- Surface Design Solutions — Surface Design Solutions uses physics-informed AI to help manufacturers reduce scrap, improve yield, and diagnose costly surface performance issues.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 59
- Round size: Seed $3M–$12M; Pre-Seed $2.1M–$4M; Series A $5M–$25M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $4.7M in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
- Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $26M in 2014
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mindset Ventures is an early-stage VC firm that supports entrepreneurs in their growth and international expansion. The firm targets B2B startups technology applied to Agriculture, Financial Services, Healthcare, Cybersecurity, Education, and Enterprise Software industry. It was founded in 2016 and headquartered in Sao Paulo, Brazil.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 112
- Round size: Seed $1.9M–$14M; Series A $5.5M–$30M; Series B $6.8M–$35M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $50M in 2019
Portfolio highlights
- Alta — Alta leverages data and AI to drive business growth 24/7.
- Belo — Crypto for everyone, everyday
- Mogul — Your path to financial success in the music business.
Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 9
- Round size: Series A $8.8M–$20M; Series B $20M–$20M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- CoreMap — CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
- Sweetch — Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized precision engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale.
- Carevive Systems — Powered by real world patient experience data, Carevive builds cancer care management tools that improve patient quality of life and survival outcomes.
Neo Ventures is a venture capital investment platform focused on deep tech, funds and high-growth startup portfolio.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 20
- Round size: Seed $500k–$2.9M; Series A $2.3M–$24M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
- Convex — All gas, no breakages. Convex is the reactive backend platform that keeps up with you and your agents.
- Extend Robotics — Extend Human Capabilities Beyond Physical Presence
GE Ventures combines capital, technical, and commercial services. They invest in the healthcare and life sciences, energy and mobility, manufacturing and supply chain, enterprise productivity applications, digital infrastructure, and frontier technologies sectors.
Show more...Investment focus
- Industry: Health Care, Software, Enterprise Software
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 164
- Round size: Series A $6M–$32M; Series B $6M–$31M; Series C $14M–$70M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- FogHorn — FogHorn is a developer of “edge intelligence” software for industrial and commercial IoT application solutions. FogHorn’s software platform brings the power of advanced analytics and machine learning to the on-premises edge environment enabling a new class of applications for advanced monitoring and diagnostics, machine performance optimization,proactive maintenance and operational intelligence use cases. FogHorn’s technology is ideally suited for OEMs, systems integrators and end customers in manufacturing, power and water, oil and gas, renewable energy, mining, transportation, healthcare, retail, as well as smart grid, smart city, smart building and connected vehicle applications.
- The Plate — Monetize your culinary talent. Publish your content and recipes, host workshops and build your community on The Plate.
- Catalant — Access on-demand consulting services for strategic business planning, data & business analytics, digital transformation, M&A, market research, and more.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 762
- Round size: Series A $9.8M–$116M; Series B $23M–$148M; Series C $19M–$160M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely actively investing — fresh fund, raised $192M in 2026
Portfolio highlights
- CoGenesys — CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. The company develops peptide and protein-based medicines for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- Bonovo Orthopedics —
Alon MedTech Ventures is active in the initiation and growth of young high-tech companies in the medical device arena. They seek to make a difference: Alon MedTech is engaged with novel technologies that improve human well-being and quality of life.Owned by leading Israeli Entrepreneur Dr Shimon Eckhouse, Alon MedTech is backed by a powerfullegacy. Dr Eckhouse has founded and invested in numerous medical technology firms, two of which are leading international companies, (ESC Medical [Lumenis] and Syneron Medical), both traded on NASDAQ.Their experience, professionalism, wide network and solid financial resources enable them to provide their companies with distinctive sponsorship. This includes such key factors as technological and managerial guidance, strategic counseling and fundraising.The objective of this private incubator is to accompany young ventures through all stages, from lab to marketplace – and beyond. From conceptualization of product through to company success, their assistance can extend for years after a company is up and running.Alon MedTech couples the highest levels of technological knowhow with long years of business acumen. The result: a rich and fertile environment for growing successful companies.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Venture - Series Unknown, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 6
- Round size: Seed $900k–$2.2M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
- Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
- Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
Shimon Eckhouse
Show more...Investment focus
- Industry: Medical, Biotechnology, Fitness
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Investment focus
- Industry: Manufacturing, Software, Biotechnology
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3533
- Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 29
- Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
- Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.
Show more...Investment focus
- Industry: Software, Analytics, Big Data
- Stage:Series B, Series A, Series C
- Geography: Israel, United States, India
Investor stats
- Total investments: 35
- Round size: Series A $4M–$7M; Series B $3.5M–$30M; Series C $10M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $50M in 2016
Portfolio highlights
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
- Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!“Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.
Show more...Investment focus
- Industry: Medical, Health Care, Therapeutics
- Stage:Seed, Grant, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 8
- Round size: Seed $1.2M–$20M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
- ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
- Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 97
- Round size: Seed $2M–$7.6M; Series A $6M–$60M; Series B $10M–$200M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — raised $9.6M in 2024
Portfolio highlights
- Jenesys AI — Meet Jack, your AI-powered bookkeeping agent, automates line-item extraction, GL coding, and bank reconciliation with real-time insights.
- Qureight — Pioneering data curation to solve complex diseases
- Maven Robotics — Maven Robotics is building the world's leading general purpose AI robots.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 309
- Round size: Seed $150k–$5.3M; Series A $1.8M–$25M; Series B $1.8M–$75M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- CloudSEK — CloudSEK leverages contextual AI to predict and prevent cyber threats. Keep your organisation safe and secure.
- NovaTract Surgical — NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
- Axerion Therapeutics — Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.Axerion was established in New Haven to develop and commercialize intellectual propertylicensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.
Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Recruiting
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 20
- Round size: Seed $700k–$22M; Pre-Seed $400k–$4.8M; Series A $5M–$17M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $30M in 2023
Portfolio highlights
- Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 2705
- Round size: Seed $850k–$9.9M; Series A $3.5M–$32M; Series B $8M–$75M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fresh fund, raised $90k in 2026
Portfolio highlights
- Particle — Afternic is a one-stop site to buy, sell and park domains. See for your self why Afternic is the world's premiere domain marketplace and exchange reseller.
- Akiba Digital — Akiba Digital is a data and technology company that provides financial intelligence solutions. Our vision is to to unlock financial opportunities for consumers, businesses and society using alternative data.
- Enact — Enact is a leading solar energy and solar software company serving homeowners, businesses, and installers. Get a free quote or request a demo today!
We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $17M–$54M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $175M in 2025
Portfolio highlights
- Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
- Archy — SaaS Practice Management Software for Dental Practices
- Lasso Security — Lasso Security defends the LLM frontier with advanced LLM Cybersecurity solutions. Embrace progress and strengthen your AI cybersecurity posture
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 16
- Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 18
- Round size: Series A $4M–$55M; Series B $15M–$40M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Shengjing Group offers businesses consulting services.
Show more...Investment focus
- Industry: Artificial Intelligence, Manufacturing, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, Israel, Malaysia
Investor stats
- Total investments: 48
- Round size: Seed $2M–$14M; Series A $2.2M–$120M; Series B $2.9M–$42M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Mojie — Mojie is a technology company that engages in the research and development of optics and AI solutions, known for its extensive development of various core technologies. The company operates research and development offices and high-end manufacturing bases.
- Tanwei Xinlian — Tanwei Xinlian serves as a domestic provider of interconnection communication solutions, offering expertise and innovation in this field.
- Fengxun Biotech — Nantong Fengxun Bio is a medical testing service provider. Its primary business focus is on testing services, cell technology research and development, and human stem cell technology development and application, among other things.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 42
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $401M in 2020
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- UltraClear — UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Endurance is a direct lending firm providing tailored senior secured credit facilities to companies and projects with proven technologies, visible commercial demand and capital requirements that are often underserved by conventional financing providers.
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 92
- Round size: Seed $600k–$6M; Series A $1M–$10M; Series B $5M–$42M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $50M in 2017
Portfolio highlights
- Baibys — Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF.
- Matics Manufacturing Analytics Ltd. — Matics real-time manufacturing analytics provides a digital toolbox for factories' production floor management and dramatically increases the production efficiency.
- STAX Engineering, Inc. — The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.
Arc Impact is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, Food and Beverage, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 10
- Round size: Seed $2M–$6.2M; Series A $10M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MDI Health — Transform Quality Metrics Clinical Outcomes & Costs all inOne Platform. Your AI Co-Pilot for Medication Management
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- 50CUT — Mush Foods is an Israeli-based food tech company, growing edible mushroom mycelium to create innovative and sustainable animal-free protein as an ingredient for the food and beverage industry. We harness the fantastic power and innate intelligence of mushrooms to face future global challenges and provide sustainable groundbreaking food solutions tothe food of the future.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 44
- Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Kimba — Kimba is the first sleep system that reads your body and responds to it silently and automatically every night, using the only sensory pathway that can reach a sleeping brain. Reserve your Kimba today!
- CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
- Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more...Investment focus
- Industry: Software, Health Care, Cyber Security
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 35
- Round size: Seed $1M–$9M; Series A $1.5M–$9M; Series B $100k–$30M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
- Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Israel HealthCare Ventures (IHCV) - a leading Israeli life sciences venture fund - was founded at the end of the year 2000. The fund is focused on providing funds (capital) to Israeli and Israeli-related companies in the fields of medical devices, pharmaceuticals, biotechnology, nanotechnology and medical-related IT.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series F
- Geography: Israel, United States
Investor stats
- Total investments: 8
- Round size: Series D $1.2M–$16M; Series F $19M–$40M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- OrSense — OrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood parameters. OrSense's NBM-200MP monitors and displays oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram andhemoglobin, all non-invasively and continuously. The system is designed for use in hospitals including operating and recovery rooms and intensive care units as well as in outpatient sites and emergency services. OrSense's non-invasive hemoglobin/hematocrit monitor was granted the CE approval and was tested on over 4,000 patients and donors at 15 sites in the U.S. and Europe. The Company's products are based on its proprietary Occlusion Spectroscopy technology, which overcomes key obstacles that hinder the performance of competing approaches.
- Gamida Cell — Gamida Cell is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regenerative power of therapeutic stem cells. Gamida Cell is a leader in the development of stem cell therapy technologies and products. The therapies are based on expanded populations of cord blood stem cells,for the treatment of illnesses with significant unmet clinical needs such as blood cancers, autoimmune and metabolic diseases as well as neutropenia.
- Lifeward — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 73
- Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
- FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
Hanaco Venture Capital is a technology company with visionary and passionate entrepreneurs. Hanaco was founded by Alon Lifshitz, Lior Prosor, and Pasha Romanovski in 2017 and is headquartered in Tel Aviv, Israel.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 102
- Round size: Seed $2.5M–$11M; Series A $4M–$33M; Series B $15M–$56M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Milestone — Milestone ensures your GenAI tools are fully integrated, optimized, and aligned with your business goals, driving measurable ROI and sustained innovation.
- Quack — Get your team the power to resolve user issues right away.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Robotics
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 276
- Round size: Seed $2M–$22M; Series A $7.4M–$50M; Series B $15M–$100M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely actively investing — fresh fund, raised $51M in 2026
Portfolio highlights
- Efficient Computer — Efficient Computer is ushering in a new era of computing with our ultra-energy-efficient programmable processors.
- prime minute — Prime Minute develops disaster response technology and a platform for emergency operations and critical infrastructure resilience.
- Reframe Systems — Robotic microfactories for building net-zero homes 2x faster, 2x cheaper with 10x lower carbon
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, India, Israel
Investor stats
- Total investments: 2426
- Round size: Seed $2M–$26M; Series A $7M–$85M; Series B $15M–$125M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $600M in 2025
Portfolio highlights
- Tennr — Tennr is a custom AI assistant that accelerates research, answers complex questions, and generates custom reports.
- Whizzo — Whizzo specializes in materials science-driven manufacturing of engineered fashion and technical textiles. Our expertise lies in creating and executing innovative textile blends tailored for applications across automotive, agriculture, medical textiles, and engineered fashion.
- ElevenLabs — Create lifelike speech with our AI voice generator and voice agents platform. Access 5,000+ voices in 70+ languages with secure APIs and SDKs.
Group 11 invests in visionary entrepreneurs who are utilizing the unstoppable momentum of AI and FinTech to redraw the landscape of their respective industries. With a goal of creating change across generations and building long term value through technology, Group 11 has emerged as a coveted partner to veteran entrepreneurs at the forefront oftheir fields. Since its inception in 2012, the firm has deployed over $600 million across six funds in some of the world’s most prominent and disruptive technology companies, including: Tipalti, Navan, Next Insurance, HomeLight, Sunbit, Masterschool, Healthee, Dream, and BridgeWise.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Series A, Series B, Seed
- Geography: United States, Israel
Investor stats
- Total investments: 83
- Round size: Seed $1.5M–$22M; Series A $6M–$34M; Series B $11M–$100M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Venn — Venn creates a new way of urban neighboring by managing homes, creating shared spaces, supporting hyperlocal business initiatives and services, programs events, and facilitating community engagement – all on a neighborhood-wide level. Operating by the motto, “If they build it, they will stay,” venn’s platform encourages urbanites to become activecreators and participants in the development of their community and enables developing neighborhoods to become as vibrant and desirable as the downtown core. Founded in 2016 by people raised in the Big City and in cooperative communities, venn is a new movement of neighboring that impacts tens of thousands of people in three cities (Tel Aviv, Brooklyn, and Berlin) with +75 employees
- Healthee — Healthee provides an AI-driven platform designed to simplify health benefits navigation for employees and employers. The platform includes a plan comparison tool that assists employees in evaluating and selecting health plans based on individual or family needs. This tool utilizes self-reported health information to provide tailoredrecommendations, streamlining the open enrollment process. Healthee also offers wellness tracking features, enabling users to monitor essential health milestones such as annual physicals, dental exams, and vision appointments. This functionality supports preventive care and encourages proactive health management.
- Dream — Dream Security provides critical infrastructure defensive cyber solutions.
Medical Investor funding in Israel at a glance
Stats across 632 deals from 667 investors.
Access all 667 investors in Israel Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 667 investors investing in Israel Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!